Mainz Biomed: Funding, Investors & Team (Sep 2026)
Mainz Biomed strives to be a prominent supplier of accessible diagnostic solutions for individuals worldwide. Our focus is on creating inventive products that efficiently detect the early stages of various life-threatening illnesses, such as colorectal and pancreatic cancers. For additional information about our company and our commitment to using science to preserve lives, please visit our website at www.mainzbiomed.com.
Mainz Biomed has raised $45.5M across 6 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Feb 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mainz Biomed Company Profile and Key Stats
Latest funding round on record: Feb 2026.
Mainz Biomed Funding Rounds
Mainz Biomed raised $22.5M in a Post-IPO Equity announced in Jan 2022.
1.8 years later, an undisclosed round of $5.0M was announced in Nov 2023.
1.1 years later, an undisclosed round of $8.0M was announced in Dec 2024.
5 months later, an undisclosed round of $4.0M was announced in May 2025.
3 months later, an undisclosed round of $3.0M was announced in Aug 2025.
6 months later, an undisclosed round of $3.0M was announced in Feb 2026.
Mainz Biomed Founders and Leadership Team
Contact details for the Mainz Biomed team: 1 of 1 has an email address on file.
Start 14-day free trial →Mainz Biomed Funding Compared to Other Biotechnology Startups
Mainz Biomed's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mainz Biomed in Biotechnology and Mainz
Companies Similar to Mainz Biomed
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Mainz Biomed Funding FAQs
What does Mainz Biomed do?
Mainz Biomed strives to be a prominent supplier of accessible diagnostic solutions for individuals worldwide. Our focus is on creating inventive products that efficiently detect the early stages of various life-threatening illnesses, such as colorectal and pancreatic cancers. For additional information about our company and our commitment to using science to preserve lives, please visit our website at www.mainzbiomed.com.
How much funding has Mainz Biomed raised?
Mainz Biomed has raised $45.5M across 6 rounds on record. The most recent is an undisclosed round of $3.0M announced in Feb 2026.
When did Mainz Biomed last raise funding?
Mainz Biomed's most recent funding round on record is an undisclosed round of $3.0M, announced in Feb 2026.
Who founded Mainz Biomed?
FundedIQ lists Guido Baechler (Founder) at Mainz Biomed.
Where is Mainz Biomed headquartered?
Mainz Biomed is based in Mainz, Rheinland-Pfalz, Germany.
How many employees does Mainz Biomed have?
Mainz Biomed is in the 51-100 employee band.
How does Mainz Biomed's funding compare to other Biotechnology startups?
Mainz Biomed's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Mainz Biomed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mainz Biomed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.